Chugai Pharmaceutical
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Chugai Pharmaceutical
RECRUITINGPhase 2NCT07239336
Study of DONQ52 in Active Celiac Disease
The main aim is to see how DONQ52 works to improve small intestinal damage and reduce celiac-related symptoms due to gluten exposure, in participants with celiac disease (CeD)...
Sponsor: Chugai PharmaceuticalEnrolling: 9211 locations
Celiac Disease
RECRUITINGPhase 1NCT06371417
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
This Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RAY121, a inhibitor of...
Sponsor: Chugai PharmaceuticalEnrolling: 14420 locations
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3